Fortrea Holdings Inc. (FTRE) Stock Score, Valuation & Financial Research
Fortrea Holdings Inc. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 20/100.
Quick answer for FTRE
Fortrea Holdings Inc. currently has a Wall Street Score of 20/100. The stored market price is $17.2. Its financial score is 29/100. Its valuation score is 0/100. The latest WSS change is -0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Fortrea Holdings Inc. does
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive tec
FTRE financial snapshot
- Wall Street Score:
- 20/100
- Current price:
- $17.2
- Market capitalization:
- $1.64B
- Revenue:
- $2.68B
- Net income:
- $-85.2M
- Free cash flow:
- $88.3M
- Cash:
- $168.6M
- Total debt:
- $1.12B
- EPS:
- -0.93
- Financial score:
- 29/100
- Valuation score:
- 0/100
- Revenue score:
- 15/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $88.3M, showing positive cash generation.
- The balance sheet shows $168.6M of cash versus $1.12B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -0.1 points: FTRE decreased 0.1 points because some fundamentals weakened.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-04.
How to research FTRE
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.